GLENBEIGH HEALTH SOURCES — History
CCN 360245 | 3-year financial timeline | COVID resilience: 31/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
-5.6%
Revenue CAGR (3yr)
12.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $28M | $26M | $25M | -6.5% | -5.6% |
| Operating Expenses | $22M | $22M | $22M | -1.5% | -1.7% |
| Operating Margin | 19.0% | 16.6% | 12.1% | -26.9% | -20.0% |
| Net Income | $5M | $4M | $3M | -31.7% | -24.5% |
| Licensed Beds | 114 | 114 | 114 | +0.0% | +0.0% |
| Total Patient Days | 24,383 | 16,280 | 22,093 | +35.7% | -4.8% |
| Medicare Day % | 10% | 10% | 6% | -35.0% | -21.1% |
| Medicaid Day % | 1% | 1% | 1% | +24.8% | +13.2% |
COVID Impact & Recovery
Resilience Score: 31/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -11.0% ($28M → $25M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-5.6%
This Hospital
+7.6%
State Avg
Latest Margin
12.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $23M | 8.7% |
| FY2024 (proj) | $22M | 5.3% |
| FY2025 (proj) | $20M | 1.9% |